In aggregate, our findings from the largest single study of breast and ovarian tumors associated with BRCA1 and BRCA2 germline mutations suggest that locus-specific LOH may be a biomarker for a BRCAness phenotype in whole tumor formalin-fixed paraffin embedded (FFPE) specimens. The gene discussed is BRCA1; the disease is neoplasm.